Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-21

Clinical Trial Update: Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section [Phase 3]

View source ↗

Summary

Phase 3 trial of chloroprocaine 3% for epidural anesthesia in unplanned cesarean sections was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroprocaine 3% (chloroprocaine)

Snippet

Sponsor: Sintetica SA | Conditions: Unplanned Caesarean Section | Phase 3 | Status: TERMINATED | Results posted: 2023-11-21